Dr. Aggarwal’s Eye Hospital Nets Patent for Innovative Drug Delivery

The Tirunelveli branch of Dr. Agarwal’s Eye Hospital gets a patent for an innovative drug delivery technique to treat deeper corneal infections effectively. “Corneal Implants” a new innovative technique that can treat Keratitis – inflammation of the cornea caused by both bacterial and fungal damages claimed by the hospital.

Lional Raj D, regional medical director of Dr. Agarwal Eye Hospital, Tirunelveli, whose team invented the technique and stated to the reporters that Keratitis problem could lead to blindness and this technique can save the user from blindness.  He also added, according to the estimations, 30% of Keratitis cases in India leads to blindness. Fortified antibiotic eye drops are the presently available measure to treat an infectious corneal disease that requires frequent administration. Due to poor penetration of drugs by eye drops, the bioavailability of antibiotics in the deeper corneal tissues is limited.

With this innovative technique, two-three months of treatment required and varies for each individual and costs ranges from Rs 6,000 to Rs 8,000. It is free from side-effects like with the use of eye-drops. The technique first implemented and tried on Antony Raj, 45, a Tamil Nadu Generation and Distribution Corporation worker in December 2016.

Related Posts

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Aakash Healthcare saves, Serving a Lesson Loud n Clear- Beware of Over- the- Counter Drugs New Delhi: Self medication is a recipe for disastrous consequences for life.  But despite daily…

All the Way from Teeth to Tee: Hole in One

6th Edition of All India Dental Fraternity Invitation Golf Tournament in Class & Style Manesar/ New Delhi: Dentistry is now a high- end domain with class and style.  6th Edition…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Gene Therapy for Cholesterol: Initial Test Results Cheer

Gene Therapy for Cholesterol: Initial Test Results Cheer

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

US Biotech Regeneron to launch Global Capability Centre in Hyderabad

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Popped the Pill, Paid the Price to Potentially Fatal Skin Syndrome

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Former Advisor to India’s Union Health Ministry gets Quite a Feather in his Cap

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states